To The Moon

$Gold - main 2606(GCmain)$On Thursday (April 16), spot gold prices held steady around $4,790 per ounce, nearly unchanged, after hitting a one-month high in the previous session. While US gold futures fell slightly by 0.3% to $4,808.30, the overall market sentiment has gradually recovered from the slump in March. This change is not an isolated event, but is closely linked to the dramatic turn of events in the Middle East—after the outbreak of the war between the US and Israel against Iran, gold prices were initially pressured by inflation concerns and tightening liquidity. However, President Trump's ceasefire declaration and positive signals from US-Iran peace negotiations are injecting strong momentum into the gold market. Inve

From my perspective, removing the PDT rule is a double-edged sword. It looks like true democratization—no more $25,000 barrier—but markets reward discipline, not access. This shift puts full responsibility on the individual, and I think many retail traders will overestimate their edge while underestimating how fast intraday losses can snowball. Looking back at past changes—from commission deregulation to the zero-commission wave led by $Robinhood(HOOD)$ and $Charles Schwab(SCHW)$ —each reform boosted access but also speculation. I s

Yes, this is a meaningful technical and psychological win, but the next move now depends less on the breakout itself and more on whether earnings can justify the speed of the rally. The S&P 500 closed at a record 7,022.95 on 16 April 2026, while the Nasdaq finished at 24,016.02, also a record. The Nasdaq is up about 15% in just the last 11 trading days, which shows powerful momentum but also raises the bar for companies reporting now.  My view: 7,000 can hold if earnings do three things. First, bellwethers need to beat on revenue and margins, not just EPS. Second, guidance must stay firm, especially around AI demand, consumer resilience, and enterprise spend. Third, management teams need to avoid cautious forward commentary, because at these valuation levels, even “good” numbers c

$D-Wave Quantum Inc.(QBTS)$ 40 TARGET PRICE, in view of NVIDIA'S probable partnership with QBTS. Primary Catalyst: NVIDIA's Industry-Wide Announcement of using Quantum Technologies developed by QBTS. The core driver was NVIDIA's launch of the "Ising" model family, the first open-source AI models specifically designed for quantum computing. This news, which broke on April 15th, acted as a powerful catalyst for the entire Quantum sector. Technical Breakthrough: The models target two major bottlenecks: quantum processor calibration and quantum error correction. Reports indicate QBTS  quantum technology can reduce calibration time from days to hours and improve error correction speed by 2.5x with triple the accuracy. This is percei

Tesla (TSLA) has followed the broader pattern seen across major global indices and completed a corrective cycle from the April 2025 low. This decline has been identified as wave II, which ended at $337.2. The stock has since turned higher. However, it must still break above the previous all‑time high at $498.8, set earlier this year, to fully invalidate the possibility of a double correction. That scenario appears less probable because major benchmarks such as the S&P 500 (ES) and Nasdaq 100 (NQ) have already pushed to new all‑time highs above their respective peaks from earlier in the year. From the wave II low, Tesla has begun to advance in a five‑wave impulsive Elliott Wave structure. The rally to $365.49 completed wave 1, and the subsequent pullback to $337.25 completed wave 2. The

$Taiwan Semiconductor Manufacturing(TSM)$ TSMC just delivered a monster Q1 2026 beat that has the entire semiconductor food chain buzzing, with net profit surging 58% year-over-year to TWD 572.5 billion and revenue climbing 35% to TWD 1.134 trillion — smashing expectations across the board and pushing gross margin to a stellar 66.2%. 😤 The HPC segment, the crown jewel of AI infrastructure, now accounts for over 60% of total revenue, while advanced nodes (3nm and 5nm) make up a record 74% of wafer revenue, proving that hyperscaler demand for cutting-edge capacity remains insatiable. Shares are up roughly 2% in after-hours trading as investors digest the strongest validation yet that AI capex is not only intact but accelerating. This performance sets

Here's a comprehensive, bullish counter-article based on the title "From Big Short to Big Miss? Why Burry's Fragile Market Warning Overlooks AI Resilience". It directly engages Burry's warnings of market fragility (e.g., stocks at record highs as a share of household wealth, parallels to pre-dot-com peaks, AI bubble too big for even government intervention to save, and predictions of prolonged bear markets or systemic collapse in 2026–2027), while highlighting AI's demonstrated resilience through strong earnings, accelerating adoption, and structural demand as of mid-April 2026.From Big Short to Big Miss? Why Burry's Fragile Market Warning Overlooks AI ResilienceMichael Burry, the legendary investor behind "The Big Short," has issued stark warnings about the fragility of today's market, pa

$Robinhood(HOOD)$ Robinhood just rocketed 10.41% to $87.32 after the SEC formally killed the Pattern Day Trader rule, scrapping the $25,000 minimum account balance requirement and instantly expanding HOOD’s addressable user base to millions of retail traders who were previously locked out. 😤 This regulatory dividend is a game-changer, removing one of the biggest barriers to active trading and opening the floodgates for smaller accounts to day trade freely. At the same time, expectations for prediction market deregulation are gaining serious traction, creating a powerful compounding policy tailwind that could turbocharge Robinhood’s product suite and user engagement. Q1 earnings on April 28 will deliver the first hard numbers on how the PDT repeal

I’m still leaning toward $DBS(D05.SI)$ and $ocbc bank(O39.SI)$ this earnings season. It’s less about peak NIM now, and more about who can offset the pressure. DBS is my more “offensive” pick — if wealth management and capital markets recover, it has the strongest upside. The key watch is its full-year NIM guidance, which will drive re-rating. OCBC remains my defensive anchor. Its wealth management strength and conservative balance sheet should cushion margin pressure. If this quarter is more about managing downside than beating expectations, I think OCBC holds up better with steadier earnings. I’m more cautious on $UOB(U11.SI)$ due to ASEAN exposure an

$NVIDIA(NVDA)$ $IONQ Inc.(IONQ)$ IonQ just delivered a massive 20.95% surge to $43.25, catapulting the quantum computing leader into the spotlight as DARPA selected it for the HARQ quantum networking program while Nvidia simultaneously unveiled its new Ising quantum-AI model. 😤 This dual validation is a game-changer, shifting quantum from a distant "long-term concept" to a dual-endorsed technology backed by U.S. government strategic needs and Big Tech’s practical AI infrastructure push. Photonic interconnect technology from IonQ is now officially in the DARPA pipeline for secure, high-speed quantum networking, while Nvidia’s Ising model integration highlights how quantum systems can accelerate AI training

$DBS(D05.SI)$ $OCBC Bank(O39.SI)$ $UOB(U11.SI)$ SG Banks earnings season is officially underway, with DBS firing the first shot on April 30, followed by UOB on May 7 and OCBC on May 8, and Goldman’s latest report delivers a clear message: overall results should be “decent enough,” but the divergence among the Big Three is becoming impossible to ignore. 😤 Net interest margin pressure remains a persistent headwind across the board as rates ease, while wealth management continues to shine as the bright spot driving non-interest income. Credit costs are the biggest hidden risk, with any unexpected spike potentially derailing the otherwise stable outlook. This e

$IONQ Inc.(IONQ)$ $NVIDIA(NVDA)$  $D-Wave Quantum Inc.(QBTS)$  📊📈📊 Quantum Options Flow Reignites: Institutional Call Buying Surges Across $IONQ $QBTS $RGTI $QUBT as $NVDA Resets the Narrative 📈📊📈 I’m watching a clear re-risking impulse emerge in one of the most speculative corners of the market, and it is not happening in isolation. 📊 The latest Bloomberg data shows daily call volumes across $IONQ, $QBTS, $RGTI and $QUBT spiking aggressively into mid-April 2026. This is not a marginal uptick. This is a sharp reacceleration that now rivals the intensity of the 2025 speculative peak. I’m seeing flow return before price fully confirms, which is

$Tesla Motors(TSLA)$ $Microsoft(MSFT)$  $Alphabet(GOOGL)$  🚀🧠⚡ $650B AI Capex Supercycle Meets $TSLA’s Terafab Gambit ⚡🧠🚀 The signal from this capex curve is unequivocal. $MSFT, $META, $GOOGL and $AMZN are collectively guiding toward ~$650B in 2026 capex, up roughly +50% YoY and more than 8x since 2020. This is not cyclical expansion. This is a structural re-architecture of global compute capacity. This spend represents the physical layer of AI scaling. Data centres, networking, power infrastructure and increasingly custom silicon are now the gating factors for competitive advantage. Compute availability, latency and cost per FLOP are becomin

My stock in focus today is $Madison Air Solutions(MAIR)$ , which just delivered the biggest IPO of 2026. Pricing at the top end & raising $2.2 bil signals solid demand & more importantly, it could reopen the IPO window ahead of potential mega listings like SpaceX and other AI names. What stands out is its niche positioning. Instead of traditional HVAC, Madison Air focuses on high-value environments like data centers, semiconductors & healthcare—areas where clean air is critical. While data centers are still a small part of revenue, the long-term tie to AI infrastructure is clear, putting it alongside peers like Carrier Global and Trane Technologies, but with a more specialized angle. Valuation is the key risk, around 35x earnings alr

Abbott Laboratories, a diversified healthcare giant with a 135+ year history, has faced investor frustration in early 2026. Its stock has pulled back sharply, trading around $95–$96 as of mid-April 2026 following a roughly 6% drop after Q1 results. The primary culprit? Continued weakness in the nutrition segment, which includes household names like Similac infant formula and Ensure adult shakes. This drag has overshadowed solid growth elsewhere, raising questions about near-term recovery and whether ABT remains a compelling long-term holding. The Nutrition Drag: What’s Happening?Abbott’s nutrition business has been a consistent underperformer. In Q4 2025, worldwide nutrition sales fell 8.9% year-over-year to $1.94 billion (9.1% organic decline), driven by U.S. market share losses—partly fr